{"id":46576,"date":"2022-07-26T14:02:05","date_gmt":"2022-07-26T12:02:05","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/anelto-names-tina-null-chief-clinical-officer\/"},"modified":"2022-07-26T14:02:05","modified_gmt":"2022-07-26T12:02:05","slug":"anelto-names-tina-null-chief-clinical-officer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/anelto-names-tina-null-chief-clinical-officer\/","title":{"rendered":"Anelto Names Tina Null Chief Clinical Officer"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Null brings to Anelto decades of healthcare leadership experience as a leader of clinical operations.<\/i>\n<\/p>\n<p>THE COLONY, Texas&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.anelto.com&amp;esheet=52788071&amp;newsitemid=20220726005027&amp;lan=en-US&amp;anchor=Anelto&amp;index=1&amp;md5=32b6df3cddac23aaeb8393bab8d01872\" rel=\"nofollow noopener\" shape=\"rect\">Anelto<\/a>, a leader in Remote Patient Monitoring (RPM) solutions, today announced that Tina Null, MSN, RN is joining the team as chief clinical officer.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220726005027\/en\/1521137\/5\/Anelto-Logo-Blue.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220726005027\/en\/1521137\/21\/Anelto-Logo-Blue.jpg\"><\/a><\/p>\n<p>\nShe brings to Anelto decades of healthcare leadership experience as a leader of clinical operations as well as health information management and patient access operations in two large integrated health systems in the central Ohio area.\n<\/p>\n<p>\n\u201cTina understands the breadth and depth of healthcare systems that ranges from acute care to home care,\u201d said Anelto President and CEO Mark Denissen. \u201cIn her new role, Tina provides leadership and oversight of all clinical programs at Anelto as we roll out solutions and services to chronic patients and their healthcare providers across the country.\u201d\n<\/p>\n<p>\nNull spent more than a decade at Ohio Health, where she was System Director &#8211; Home Care-Hospice, leading a team of mid-level managers in operationalizing the business&#8217;s strategic plan to accommodate continued growth, standardize operations across sites and centralize support services. As part of the Ohio Health system, she was also director of nursing at Dublin Methodist and Grady Memorial Hospitals and director of health information management &amp; patient access at Marion General Hospital.\n<\/p>\n<p>\n\u201cAnelto is transforming clinical care through remote patient monitoring,\u201d Null said. \u201cI am happy to be working with a company at the forefront of industry innovation in healthcare as we provide cutting-edge solutions for patients to avoid frequent trips to the emergency department or doctor\u2019s office.\u201d\n<\/p>\n<p>\nIn addition to her leadership roles, Null has served as Six Sigma Black Belt project manager, a change management practitioner, and most recently a clinical consultant in the RPM space at Vivify Health.\n<\/p>\n<p>\nNull is a graduate of The Ohio State University, where she obtained her bachelor\u2019s degree in Nursing, and Capital University, where she received her master\u2019s degree in Nursing Administration.\n<\/p>\n<p>\nFor more information on Anelto\u2019s RPM solutions, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.anelto.com&amp;esheet=52788071&amp;newsitemid=20220726005027&amp;lan=en-US&amp;anchor=www.anelto.com&amp;index=2&amp;md5=d5864035d83156a87cd4f6326d0ca01d\" rel=\"nofollow noopener\" shape=\"rect\">www.anelto.com<\/a>.\n<\/p>\n<p>\n<b>About Anelto<\/b>\n<\/p>\n<p>\nFounded 2012, Anelto has raised the bar in senior care with the goal of enabling a healthier, more independent aging population. Anelto&#8217;s leading technology platform offers a Personal Emergency Response System (PERS) and Remote Patient Monitoring (RPM), keeping seniors connected to healthcare providers and emergency medical care, regardless of location. The company&#8217;s solutions are scalable for healthcare organizations of all sizes and were created by a team seeking better solutions for the ever-growing elderly population. For more information, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.anelto.com&amp;esheet=52788071&amp;newsitemid=20220726005027&amp;lan=en-US&amp;anchor=www.anelto.com&amp;index=3&amp;md5=9da7925768725da6848232f43f219233\" rel=\"nofollow noopener\" shape=\"rect\">www.anelto.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nKristine Bennett, Calysto Communications<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;&#x74;o&#58;&#107;&#x66;&#x62;e&#110;&#110;&#x65;&#x74;t&#64;&#99;&#x61;&#x6c;&#x79;s&#116;&#x6f;&#x2e;&#x63;o&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6b;&#x66;&#98;&#101;n&#x6e;&#x65;&#x74;&#116;&#64;c&#x61;&#x6c;&#x79;&#115;&#116;o&#x2e;&#x63;&#x6f;&#109;<\/a><br \/>404-266-2060 x13\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Null brings to Anelto decades of healthcare leadership experience as a leader of clinical operations. THE COLONY, Texas&#8211;(BUSINESS WIRE)&#8211;Anelto, a leader in Remote Patient Monitoring (RPM) solutions, today announced that Tina Null, MSN, RN is joining the team as chief clinical officer. She brings to Anelto decades of healthcare leadership experience as a leader of &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/anelto-names-tina-null-chief-clinical-officer\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46576","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Anelto Names Tina Null Chief Clinical Officer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/anelto-names-tina-null-chief-clinical-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anelto Names Tina Null Chief Clinical Officer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Null brings to Anelto decades of healthcare leadership experience as a leader of clinical operations. THE COLONY, Texas&#8211;(BUSINESS WIRE)&#8211;Anelto, a leader in Remote Patient Monitoring (RPM) solutions, today announced that Tina Null, MSN, RN is joining the team as chief clinical officer. She brings to Anelto decades of healthcare leadership experience as a leader of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/anelto-names-tina-null-chief-clinical-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-26T12:02:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220726005027\/en\/1521137\/21\/Anelto-Logo-Blue.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anelto-names-tina-null-chief-clinical-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anelto-names-tina-null-chief-clinical-officer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Anelto Names Tina Null Chief Clinical Officer\",\"datePublished\":\"2022-07-26T12:02:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anelto-names-tina-null-chief-clinical-officer\\\/\"},\"wordCount\":438,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anelto-names-tina-null-chief-clinical-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220726005027\\\/en\\\/1521137\\\/21\\\/Anelto-Logo-Blue.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anelto-names-tina-null-chief-clinical-officer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anelto-names-tina-null-chief-clinical-officer\\\/\",\"name\":\"Anelto Names Tina Null Chief Clinical Officer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anelto-names-tina-null-chief-clinical-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anelto-names-tina-null-chief-clinical-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220726005027\\\/en\\\/1521137\\\/21\\\/Anelto-Logo-Blue.jpg\",\"datePublished\":\"2022-07-26T12:02:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anelto-names-tina-null-chief-clinical-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anelto-names-tina-null-chief-clinical-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anelto-names-tina-null-chief-clinical-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220726005027\\\/en\\\/1521137\\\/21\\\/Anelto-Logo-Blue.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220726005027\\\/en\\\/1521137\\\/21\\\/Anelto-Logo-Blue.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anelto-names-tina-null-chief-clinical-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anelto Names Tina Null Chief Clinical Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anelto Names Tina Null Chief Clinical Officer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/anelto-names-tina-null-chief-clinical-officer\/","og_locale":"en_US","og_type":"article","og_title":"Anelto Names Tina Null Chief Clinical Officer - Pharma Trend","og_description":"Null brings to Anelto decades of healthcare leadership experience as a leader of clinical operations. THE COLONY, Texas&#8211;(BUSINESS WIRE)&#8211;Anelto, a leader in Remote Patient Monitoring (RPM) solutions, today announced that Tina Null, MSN, RN is joining the team as chief clinical officer. She brings to Anelto decades of healthcare leadership experience as a leader of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/anelto-names-tina-null-chief-clinical-officer\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-26T12:02:05+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220726005027\/en\/1521137\/21\/Anelto-Logo-Blue.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/anelto-names-tina-null-chief-clinical-officer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/anelto-names-tina-null-chief-clinical-officer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Anelto Names Tina Null Chief Clinical Officer","datePublished":"2022-07-26T12:02:05+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/anelto-names-tina-null-chief-clinical-officer\/"},"wordCount":438,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/anelto-names-tina-null-chief-clinical-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220726005027\/en\/1521137\/21\/Anelto-Logo-Blue.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/anelto-names-tina-null-chief-clinical-officer\/","url":"https:\/\/pharma-trend.com\/en\/anelto-names-tina-null-chief-clinical-officer\/","name":"Anelto Names Tina Null Chief Clinical Officer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/anelto-names-tina-null-chief-clinical-officer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/anelto-names-tina-null-chief-clinical-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220726005027\/en\/1521137\/21\/Anelto-Logo-Blue.jpg","datePublished":"2022-07-26T12:02:05+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/anelto-names-tina-null-chief-clinical-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/anelto-names-tina-null-chief-clinical-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/anelto-names-tina-null-chief-clinical-officer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220726005027\/en\/1521137\/21\/Anelto-Logo-Blue.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220726005027\/en\/1521137\/21\/Anelto-Logo-Blue.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/anelto-names-tina-null-chief-clinical-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Anelto Names Tina Null Chief Clinical Officer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46576","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46576"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46576\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46576"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46576"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46576"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}